WINDTREE THERAPEUTICS INC /DE/ Amortization of Debt Issuance Costs
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Amortization of Debt Issuance Costs of $12.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2016-03-29
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs for the quarter ending 2014-12-31 was $4.00K, a 20.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs for the quarter ending 2014-09-30 was $5.00K, a 0.00% change year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs for the quarter ending 2014-06-30 was $5.00K, a 0.00% change year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs for the quarter ending 2014-03-31 was $5.00K, a 0.00% change year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs for fiscal 2015 was $12.00K, a 36.84% decline from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs for fiscal 2014 was $19.00K, a 5.56% increase from fiscal 2013.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs for fiscal 2013 was $18.00K.
- WINDTREE THERAPEUTICS INC /DE/ amortization of debt issuance costs for fiscal 2012 was $0.00.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2015-12-31 | $12.00K 10-K · filed 2016-03-29 | |||
| 2014-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $9.00K derived: sum of 2 quarters · filed 2016-03-29 | $14.00K derived: sum of 3 quarters · filed 2016-03-29 | $19.00K 10-K · filed 2016-03-29 |
| 2014-09-30 | $5.00K 10-Q · filed 2014-11-07 | $10.00K derived: sum of 2 quarters · filed 2014-11-07 | $15.00K 10-Q · filed 2014-11-07 | $20.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2014-06-30 | $5.00K 10-Q · filed 2014-08-07 | $10.00K 10-Q · filed 2014-08-07 | $15.00K derived: sum of 3 quarters · filed 2015-03-16 | $20.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2014-03-31 | $5.00K 10-Q · filed 2014-05-12 | $10.00K derived: sum of 2 quarters · filed 2015-03-16 | $15.00K derived: sum of 3 quarters · filed 2015-03-16 | $20.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $10.00K derived: sum of 2 quarters · filed 2015-03-16 | $15.00K derived: sum of 3 quarters · filed 2015-03-16 | $18.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $5.00K 10-Q · filed 2014-11-07 | $10.00K derived: sum of 2 quarters · filed 2014-11-07 | $13.00K 10-Q · filed 2014-11-07 | $15.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $5.00K 10-Q · filed 2014-08-07 | $8.00K 10-Q · filed 2014-08-07 | $10.00K derived: sum of 3 quarters · filed 2015-03-16 | $10.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $5.00K 10-Q · filed 2013-05-07 | $5.00K derived: sum of 2 quarters · filed 2015-03-16 | $5.00K derived: sum of 3 quarters · filed 2015-03-16 | $5.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | ||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |